Articles by Disease (Embolism And Thrombosis )

Small Peptide Radiopharmaceuticals in the Imaging of Acute Thrombus

Journal: Current Pharmaceutical Design
Volume: 8
Page: 1815-1826
Author(s): Jay E. Blum and Hirsch Handmaker

The Effects of Drugs Used in Anaesthesia on Platelet Membrane Receptors and on Platelet Function

Journal: Current Drug Targets
Volume: 3
Page: 247-258
Author(s): Sibylle A. Kozek-Langenecker

Catechol-O-Methyltransferase (COMT)-Mediated Methylation Metabolism of Endogenous Bioactive Catechols and Modulation by Endobiotics and Xenobiotics: Importance in Pathophysiology and Pathogenesis

Journal: Current Drug Metabolism
Volume: 3
Page: 321-349
Author(s): Bao Ting Zhu

Tamoxifen in the Treatment of Hepatocellular Carcinoma: 5-Year Results of the CLIP-1 Multicentre Randomised Controlled Trial

Journal: Current Pharmaceutical Design
Volume: 8
Page: 1013-1019
Author(s): M. Stanzione, S. Pignata, M. Di Maio, E. De Maio, O. G. Manghisi, M. Felder, M. Persico, M. Russo, F. Castiglione, I De Sio, A. Aiello, D. Mattera, F. Perrone, M. Calandra, G. Piai, S. Elba, F. Farinati, R. Mazzanti, L. E. Adinolfi, G. Capuano, F. Izzo, G. B. Gaeta, B. Daniele and C. Gallo

Articles by Disease (Embolism And Thrombosis )

Small Peptide Radiopharmaceuticals in the Imaging of Acute Thrombus

The Effects of Drugs Used in Anaesthesia on Platelet Membrane Receptors and on Platelet Function

Catechol-O-Methyltransferase (COMT)-Mediated Methylation Metabolism of Endogenous Bioactive Catechols and Modulation by Endobiotics and Xenobiotics: Importance in Pathophysiology and Pathogenesis

Tamoxifen in the Treatment of Hepatocellular Carcinoma: 5-Year Results of the CLIP-1 Multicentre Randomised Controlled Trial

AMPA Receptor Antagonists with Additional Mechanisms of Action: New Opportunities for Neuroprotective Drugs?

Leech Thrombin Inhibitors

Beneficial Neurobiological Effects of Melatonin Under Conditions of Increased Oxidative Stress

Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies

Use of Recombinant Human Erythropoietin as an Antianemic and Performance Enhancing Drug